Thanks, Mr. Chair.
I will be quick because MP Don Davies actually brought this up. It's about our ability to hear from patient groups or pharmaceutical companies, whatever representative sample or whoever makes up that representative sample. We need to also take into account the ability to hear from people by Zoom, in addition to written statements and things of that nature. I think it's going to be really key here for this particular motion.
Thanks so much.